PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2005 | 51 | 2 |

Tytuł artykułu

Diagnostyka ludzkiej anaplazmozy granulocytarnej

Treść / Zawartość

Warianty tytułu

Języki publikacji

PL

Abstrakty

EN
Diagnostics of human granulocytic anaplasmosis. Human granulocytic anaplasmosis is one of recently emerging tick-borne diseases. The paper summarizes current opinions on diagnostics of this zoonosis, including the recent recommendations of ESCAR (European Society of Clinical Microbiology and Infectious Diseases Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella).

Wydawca

-

Rocznik

Tom

51

Numer

2

Opis fizyczny

s.109-114,tab.,bibliogr.

Twórcy

autor
  • Akademia Medyczna, ul.Zurawia 14, 15-540 Bialystok
autor

Bibliografia

  • [1] Chen S.M., Dumler J.S., Bakken J.S., Walker D.H. 1994. Identification of a granulocytoropic Ehrlichia species as the etiologie agent of human disease. Journal of Clinical Microbiology 32: 589-595.
  • [2] Olano J.P., Walker D.H. 2002. Human ehrlichioses. Medical Clinics of North America 86: 375-392.
  • [3] Parola P. 2004. Tick-borne rickettsial diseases: emerging risks in Europe. Comparative Immunology, Microbiology & Infectious Diseases 27: 297-304.
  • [4] Grzeszczuk A, , Stańczak J., Kubica-Bierant B., Kruminis-Łozowska W., Racewicz M. 2000. First seroepidemiological evidence of human granulocytic ehrlichiosis (HGE) in Poland. Preliminary results. VIII European Multicolloquium of Parasitology (EMOP) Poznań, Poland 2000, Acta Parasitologica 45: 219-19.
  • [5] Stańczak J., Gabre R.M., Kruminis-Łozowska W., Racewicz M., Kubica-Biernat B. 2004. Ixodes ricinus as a vector of Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum and Babesia microti in urban and suburban forests. Annals of Agricultural and Environmental Medicine 11: 109-114.
  • [6] Grzeszczuk A., Stańczak J., Kubica-Biernat B., Racewicz M., Kruminis-Łozowska W., Prokopowicz D. 2004. Human anaplasmosis in north-eastern Poland: seroprevalence in human and prevalence in Ixodes ricinus ticks. Annals of Agricultural and Environmental Medicine 11: 99-103.
  • [7] Grzeszczuk A., Ziarko S., Radziwon P.M., Prokopowicz D. 2004. Zakażenie żubrów z Puszczy Białowieskiej bakteriami Anaplasma phagocytophilum. Medycyna Weterynaryjna 60: 600-601.
  • [8] Grzeszczuk A., Ziarko S., Kovalchuk O., Stańczak J. 2005. Etiology of tick-borne febrile illnesses in adult residents of North-Eastern Poland. Report from a prospective clinical study. International Journal of Medical Microbiology (in press).
  • [9] Petrovec M., Lotrič-Furlan S., Avsič-Županc T., Strle F., Brouqui P., Roux V., Dumler J.S. 1997. Human disease in Europe caused by a granulocytic Ehrlichia species. Journal of Clinical Microbiology 35: 1556-1559.
  • [10] Tylewska-Wierzbanowska S., Chmielewski T., Kondrusik M., Hermanowska-Szpakowicz T., Sawicki W., Sułek K. 2001. First cases of acute human granulocytic ehrlichiosis in Poland. European Journal of Clinical Microbiology and lnfectious Diseases 20: 196-198.
  • [11] Dumler J.S., Barbet A.F., Bekker C.P.J., Dasch G.A., Palmer G.H., Ray S.G., Rikihisa Y., Rurangirwa F.R. 2001. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales; unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia; description of five new species combinations; and designation of Ehrlichia equi and HGE agent as subjective synonyms of Ehrlichia phagocytophila. International Journal of Systematic and Evolutionary Microbiology 51: 2145-2165.
  • [12] Macleod J. 1932. Preliminary studies in the tick transmission of louping ill II. A study of the reaction of sheep to tick infestation. Veterinary Journal 88: 276-284.
  • [13] Brouqui P., Bacellar F., Baranton G., Birtles R.J., Bjöersdorff A., Blanco J.R., Caruso G., Cinco M., Foumier P.E., Francavilla E., Jensenius M., Kazar J., Laferel H., Lakos A., Lotric-Furlan S., Maurin M., Oteo J.A., Parola P., Perez-Eid C., Peter O., Postic D., Rault D., Tellez A., Tseleniz Y., Wilske B. 2004. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clinical Microbiology and Infection 10: 1108-1132.
  • [14] Bakken J.S., Dumler J.S. 2000. Human granulocytic ehrlichiosis. Clinical lnfectious Diseases 31: 554-560.
  • [15] Dumler J.S., Walker H.D. 2001. Tick-borne ehrlichioses: more of them, higher incidences, and greater 113 clinical diversity. Lancet lnfectious Diseases 1: 21-28 (preview edition).
  • [16] McQuiston J.H., Paddoc C.D., Holman R.C., Childs J.E. 1999. The human ehrlichioses in the United States. Emerging Infectious Diseases 5: 635-42.
  • [17] Weinberg G.A. 2001. Laboratory diagnosis of ehrlichiosis and babesiosis. Pediatrie Infectious Diseases. 20: 435-437.
  • [18] Aguero-Roselfeld M.E., Dumler J.S. 2003. Ehrlichia, Analasma, Neorickettsia and Aegyptianella. W: Manual of Clinical Microbiology (Red. P.R. Murray). ASM Press, Washington, D.C: 1015-1029.
  • [19] Bomski H. 1989. Podstawowe laboratoryjne badania hematologiczne. PZWL, Warszawa.
  • [20] Krzemińska-Ławkiewiczowa J., Maja S. 1993. Atlas hematologii klinicznej. PZWL, Warszawa.
  • [21] Aguero-Roselfeld M.E., Horowitz H.W., Wormser G.P., McKenna D.F., Nowakowski J., Munoz J., Dumler J.S. 1996. Human granulocytic ehrlichiosis (HGE): a case series from a single medical center in New York State. Annals of Internal Medicine 125: 904-908.
  • [22] Bakken J.S., Krueth J., Wilson-Nordskog C., Tilden R.L., Asanovich K., Dumler J.S. 1996. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275: 199-205.
  • [23] Bakken J.S., Aguero-Roselfeld M.E., Tilden R.L., Wormser G.P., Horowitz H.W., Raffalli J.T., Baluch M., Riddell D., Dumler J.S. 2001. Serial measurements of hematologie counts during the active phase of human granulocytic ehrlichiosis. Clinical Infectious Diseases 32: 862-870.
  • [24] Aguero-Roselfeld M.E., Kalantarpour F., Baluch M., Horowitz H.W., McKeana D.F., Raffalli J.T., Hsiech T-Ch., Wu J., Dumler J.S., Wormser G.P. 2000. Serology of culture-confirmed cases of human granulocytic ehrlichiosis. Journal of Clinical Microbiology 38: 635-638. .
  • [25] Bakken J.S., Goellner P., Van Etten M., Boyle D.Z., Swonger O.L., Mattson S., Krueth J., Tilden R.L., Asanovich K., Walls J., Dumler J.S. 1998. Seroprevalence of human granulocytic ehrlichiosis (HGE) and risk factors associated with infection among residents in northwestem Wisconsin. Clinical lnfectious Diseases 27: 1491-1496.
  • [26] Dumler J.S. 2003. Molecular methods for ehrlichiosis and Lyme disease. Clinics in Laboratory Medicine 23: 867-884.
  • [27] Massung R.F., Slater K., Owens J.H., Nicholson W.L., Mather T.N., Solberg V.B., Olson J.G. 1998. Nested PCR for detection of granulocytic ehrlichiae. Journal of Clinical Microbiology 36: 1090-1095.
  • [28] Lotrič-Furlan S., Petrovec M., Avsič-Županc T., Sterle F. 2005. Concomitant tick-borne encephalitis and human granulocytic ehrlichiosis. Emerging lnfectious Diseases 11: 485-488.
  • [29] Arnež M., Petrovec M., Lotrič-Furlan S., Avsič Županc T., Strle F. 2003. First European pediatrie case of human granulocytic ehrlichiosis. Journal of Clinical Microbiology 39: 4591-4592.
  • [30] Massung R.F., Slater K.G. 2003. Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum. Journal of Clinical Microbiology 41: 717-722.
  • [31] Walls J.J., Caturegli P., Bakken J.S., Asanovich K.M., Dumler J.S. 1999. Improved sensitivity of PCR for HE using epakn 1 gene of Ehrlichia phagocytophila group ehrlichiae. W: Rickettsiae and rickettsial diseases at the turn of third millennium. (Red. D. Raoult, P. Bouqui) Elsevier, Amsterdam, Lausanne, NY, Oxford, Paris, Shannon, Tokyo.
  • [32] Schouls L.M., Van De Pol I., Rijpkema S.G. 1999. Detection and identification of Ehrlichia, Borrelia burgdorfeń sensu lato, and Bartonella species in Duch Ixodes ńcinus tiqks. Journal of Clinical Microbiology 37: 2215-2222.
  • [33] Parola P., Roux V., Camicas J.L., Baradji J., Brouqui P., Raoult D. 2000. Detection of ehrlichiae in African ticks by polymerase chain reaction. Translations of Royal Society of Tropical Medicine and Hygiene 94: 707-708.
  • [34] Goodman J.L., Nelson C., Vitale B., Madigan J.E., Dumler J.S., Kurtti T.J., Munderloh U.G. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. New England Journal of Medicine 334: 209-215.
  • [35] Brouqui P., Salvo E., Dumler J., Raoult D. 2001. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clinical and Diagnostc Laboratory Immunology 8: 199-202.
  • [36] Bjöersdorff A, Brouqui P., Eliasson I., Massung R.F., Wittesjo B., Berlund J. 1999. Serological evidence of Ehrlichia infection in Swedish Lyme borreliosis patients. Scandinavian Journal of Infectious Diseases 31: 51-55.
  • [37] Lotrič-Furlan S., Petrovec M., Avsič-Županc T. et al. 2001. Clinical and serological follow up of patients with human granulocytic ehrlichiosis in Slovenia. Clinical and Diagnostic Laboratory Immunology 8: 899-903.
  • [38] Pusterla N., Weber R., Wolfensberger C., Schar G., Zbinden R., Pierz W., Madigan J.E., Dumler J.S., Lutz H. 1998. Serological evidence of human granulocytic ehrlichiosis in Switzerland. European Journal of Clinical Microbiology & lnfectious Diseases 17: 207-209.
  • [39] Skarphedinsson S., Sogaard P, Pedersen C. 2001. Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. Scandinavian Journal of Infectious Diseases 33: 206-210.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-fd4e5c23-8807-4ad4-ad2f-32b539a5e580
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.